Catheter Precision (VTAK) announced that the recent addition of key ablation procedures to ambulatory surgery centers, ASC, by Centers for Medicare and Medicaid services, CMS, provides a unique and new opportunity to expand the commercialization of LockeT. In a recent announcement by Heart Rhythm Advocates it was stated that beginning January 1, 2026, CMS has added EP ablation codes to the ASC-Covered Procedures List. David Jenkins, CEO of Catheter Precision, said, “Historically, ambulatory surgery centers have been cost conscious and workflow oriented. ASCs do not have the capability to admit patients overnight and therefore want to obtain products that increase workflow efficiency to move patients to discharge quickly while ensuring that products are safe and cost effective. The LockeT suture retention device is not only cost effective, but aids in quick hemostasis enabling same day discharge. The announcement of the new CMS codes allows for additional patient scheduling and new facilities for LockeT to continue aiding physicians and patients in post-ablation recovery.”
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VTAK:
- Catheter Precision Ends At-Market-Offering Agreement
- Catheter Precision announces successful LockeT launch in South Africa
- Catheter Precision announces third VIVO installation in France
- Catheter Precision enters distribution agreement with FuMedica
- Catheter Precision Increases Authorized Shares to 500 Million
